Bladder urothelial cell carcinoma (UCC) is an increasingly prevalent cancer worldwide, and thus, gaining a better understanding of its identifiable risk factors is a global priority. This study addressed this public health need with the understanding that cancer-initiating events, such as chromosome breakage, loss and rearrangement, can be reasonably used as biomarkers to evaluate an individual's cancer risk.
Overall, forty bladder cancer patients and twenty controls were evaluated for genomic instability. To the best of the investigators' knowledge, this is the first study to perform micronucleus (MN) assays simultaneously in urothelial exfoliated cells (UEC), buccal exfoliated cells (BEC), and peripheral blood lymphocytes (PBL) in first-diagnosed, non-smoker bladder UCC patients. Additionally, the frequency of nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) in PBL was evaluated. The MN frequencies in UEC, BEC, and PBL, as well as the frequencies of NPBs and NBUDs, were significantly higher in patients than in controls. In conclusion, MN assays, particularly in UEC, may be used to identify individuals who are at high risk of developing UCC, as single or as additional triage test to UroVysion FISH test. Our results further validate the efficacy of biomarkers, such as MN, NPBs, and NBUDs, as predictors of genomic instability.
Scientific reports. 2018 Dec 14*** epublish ***
Arjeta Podrimaj-Bytyqi, Ana Borovečki, Qerim Selimi, Suzana Manxhuka-Kerliu, Goneta Gashi, Isa R Elezaj
Institute of Pathology, Faculty of Medicine, University of Pristina "Hasan Prishtina", Pristina, Kosovo. ., Institute of Pathology "Enge", Zürich, Switzerland., Department of Biology, Faculty of Natural Sciences, University of Pristina "Hasan Prishtina", Pristina, Kosovo., Institute of Pathology, Faculty of Medicine, University of Pristina "Hasan Prishtina", Pristina, Kosovo.